A detailed history of Breakwater Investment Management transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Breakwater Investment Management holds 4 shares of GILD stock, worth $454. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4
Holding current value
$454
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 02, 2025

BUY
$108.22 - $120.47 $432 - $481
4 New
4 $444,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $142B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Breakwater Investment Management Portfolio

Follow Breakwater Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Breakwater Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Breakwater Investment Management with notifications on news.